Rachel Humphrey's Net Worth

$1.03 Million

Estimate Recalculated Aug 22, 2024 05:04PM EST

Who is Rachel Humphrey?

Rachel Humphrey has an estimated net worth of $1.03 Million. This is based on reported shares across multiple companies, which include Mirati Therapeutics, Inc., Xilio Therapeutics, Inc., Pyxis Oncology, Inc., CytomX Therapeutics, Inc., and Black Diamond Therapeutics, Inc..

SEC CIK

Rachel Humphrey's CIK is 0001579781

Past Insider Trading and Trends

2018 was Rachel Humphrey's most active year for acquiring shares with 3 total transactions. Rachel Humphrey's most active month to acquire stocks was the month of December. 2018 was Rachel Humphrey's most active year for disposing of shares, totalling 4 transactions. Rachel Humphrey's most active month to dispose stocks was the month of January. 2018 saw Rachel Humphrey paying a total of $264,588.00 for 140,000 shares, this is the most they've acquired in one year. In 2018 Rachel Humphrey cashed out on 80,000 shares for a total of $1,200,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Mirati Therapeutics, Inc. (MRTX) No price found

EVP and Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.64

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Pyxis Oncology, Inc. (PYXS) Snapshot price: $3.71

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+66.72%
38.74K
—
—
96.81K
Mar 26
Form 4
∞
58.06K
—
—
58.06K
Mar 24
Form 4
—
0
—
—
0
Aug 11
Form 3
—
0
—
—
0
No matching records found

CytomX Therapeutics, Inc. (CTMX) Snapshot price: $1.44

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 25
Form 4
—
0
$18.31
-$377,906.45
30.23K
Scheduled
Mar 2
Form 4
—
0
$18.31
-$557,505.55
30.23K
Scheduled
Feb 28
Form 4
—
0
—
—
0
Jan 24
Form 4
+100.00%
15.12K
$6.61
$99,994.42
30.23K
Dec 15
Form 4
—
0
—
—
0
Jan 25
Form 4
∞
15.12K
$6.61
$99,994.42
15.12K
Dec 28
Form 4
—
0
—
—
0
Jan 21
Form 3
—
0
—
—
0
No matching records found

Black Diamond Therapeutics, Inc. (BDTX) Snapshot price: $3.86

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 17
Form 4
∞
10K
—
—
10K
Sep 8
Form 3
—
0
—
—
0
No matching records found